News

Dow will start seeing a boost to profitability from the shutdowns in 2026. The stock has dropped 29.1% in 2025, making it the Materials Select Sector SPDR ETF's XLB worst performing component over ...
Cleanaway is an active acquirer, with almost AUD 2 billion of acquisitions in other waste management companies and assets over the decade to 2023. We expect it to continue to acquire companies, ...
The European Union is still hoping to secure a bare-bones trade deal with the U.S. by July 9 after President Donald Trump and Treasury Secretary Scott Bessent said that tariffs on U.S. trading ...
Lexeo Therapeutics received a breakthrough therapy designation from the Food and Drug Administration for its treatment for Friedreich's ataxia. Ataxia is a rare, inherited disease that damages the ...
A survey of central bank reserve managers commissioned by UBS finds that nearly half thinks the unthinkable - that the U.S. restructuring its debt is a "plausible" scenario.
If you're invested in the so-called Magnificent Seven stocks, here's what you can do to boost your portfolio's performance: Kick out Tesla (TSLA) and Apple (AAPL). Then, to replace Tesla and Apple, ...
Universal entered into a definitive agreement in December for its Virgin Music Group label to buy Downtown for $775 million in cash, hoping to tap its services across music publishing, distribution ...
The unemployment rate for Gen Z graduates with a master's degree or higher averaged 5.8% in the first half of 2025, up from just 3% in the same six-month span a year earlier, based on data from the St ...
As the markets hits a crest there will be more volatility to come, he says, similar perhaps to the rotation in July last year. "Stay buckled up, the ride promises to get wilder still." But there's ...
The National Highway Traffic Safety Administration said the Office of Defects Investigation is opening a recall query following consumer reports describing post-recall remedy failures in certain Ram ...
KalVista Pharmaceuticals shares jumped in premarket trading Monday after the company said it has received regulatory approval for its treatment of hereditary angioedema. Shares traded 20% higher ahead ...
Tesla investors faced a rough start to the week, with shares dropping after Chief Executive Elon Musk's plan for a new U.S. political party drew the ire of President Donald Trump - and one downgrade.